Catalent, a Somerset-based provider of advanced delivery technologies, announced on Thursday it has completed the $14 million expansion of its biologics packaging capabilities at its Bloomington, Indiana facility.
The expansion added 15,000 square feet of capacity to the 875,000-square-foot manufacturing site, including five new packaging suites and a new quality control lab.
“The completion of this expansion marks a major milestone for our late-stage and commercial customers, allowing Catalent to focus on more complex device assembly and packaging needs for biologic products at higher volumes,” Mike Riley, region president, Biologics North America, said. “This state-of-the-art equipment adds to our growing network of global packaging capabilities alongside our Brussels, Belgium, and Anagni, Italy drug product manufacturing sites.”
